Faeth Therapeutics

About Faeth Therapeutics

Faeth Therapeutics is pioneering a new treatment paradigm for fighting cancer by focusing on metabolism. They aim to rethink the science of cancer through metabolic approaches, utilizing computational biology, AI, and machine learning to develop multi-nodal treatments that inhibit cancer cell growth.

Products & Services

Clinical Trials:Faeth offers multiple ongoing clinical trials where patients receive support from coaches through the Faeth app to ease program adjustment.

Cancer Metabolism Treatments:Developing treatments targeting cancer metabolism using a systematic approach with computational biology and AI to fully inhibit cancer cell growth.

Specialties

Cancer Metabolism Computational Biology Artificial Intelligence Machine Learning Multi-nodal Treatment Approaches

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Strategic Raise T: - FT: Strategic Raise	A: 25000000 MR: - FA: $25 million FAN: 25000000	D: 2025-10-20 FD: 2025-10-20	9 investors

Strategic Raise Latest

2025-10-20

$25.0M

9 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Alan Sun

Head of Product

LinkedIn (Pro only)

A

Anand Parikh

CEO & Co-Founder

LinkedIn (Pro only)

C

Chandrasekhar Mothali

Head of Engineering

LinkedIn (Pro only)

D

Debbie Chirnomas

Chief Medical Officer

O

Oliver Maddocks

Chief Scientific Officer & Co-Founder

T

Tina Niazi

Head of Clinical Operations

View 26 more team members with Pro

Unlock Full Team Directory

Recent News